Autism Spectrum Disorder (ASD) Treatment Market - Forecast(2021 - 2026)

 Autism Spectrum Disorder (ASD) Treatment Market Overview

Autism Spectrum Disorder (ASD) Treatment Market size is estimated to reach $4,612.1 million by 2026, growing at a CAGR of 4.3% over 2021-2026. Autism spectrum disorder is a kind of disability that occurs owing to social and behavioral challenges and the disorder differs from person to person. Various kinds of autism type such as asperger syndrome and pervasive developmental disorder that causes owing to neurodevelopment disorder. Anticonvulsants drugs are also known as antiepileptic drugs that are very effective in autism spectrum disorders which is widely administered to patients with autistic spectrum disorder. Similarly, antipsychotics treatment is beneficial for the patients with ASD for the treatment of physical aggression, and self-injurious behaviors of patients. Insomnia is common in adults with autism spectrum disorder that causes difficulty in initiating and maintaining sleep. The risk of epilepsy are also common for the people who are suffering from autism spectrum disorder. Increasing government funding & sponsored awareness programs and growing technological advancement is the major factor driving the growth of this market. Furthermore, increasing research and development activities in medical industry and increasing prevalence of autism disorder is set to further enhance the overall market demand for Autism Spectrum Disorder (ASD) Treatment Market for the period 2021-2026. 

Report Coverage

The report: “Autism Spectrum Disorder (ASD) Treatment Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Autism Spectrum Disorder (ASD) Treatment Market. 

By Autism Type: Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder and Childhood Disintegrative Disorder.

• Request Sample

By Treatment: Behavioral Approaches, Early Intervention, Medication, Dietary Approach and Others.

By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa).

Key Takeaways

Geographically, in 2020, North America dominated the Autism Spectrum Disorder (ASD) Treatment Market owing to rising prevalence of autism and pervasive developmental disorders (PDD) and growing awareness about autism among the patient.

Increasing Government Funding & Sponsored Awareness Programs and growing technological advancement are likely to aid in the market growth of the Autism Spectrum Disorder (ASD) Treatment.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Autism Spectrum Disorder (ASD) Treatment Market report. 

Lack of skilled professional to diagnose autism spectrum disorder is set to create hurdles for the Autism Spectrum Disorder (ASD) Treatment Market.

• Inquiry Before Buying

Autism Spectrum Disorder (ASD) Treatment Market Size, By Treatment 2020-2026 (USD Million)

Autism Spectrum Disorder (ASD) Treatment Market

For More Details on This Report - Request for Sample

Autism Spectrum Disorder (ASD) Treatment Segment Analysis – By Autism Type

The global Autism Spectrum Disorder (ASD) Treatment Market based on Autism Type can be further segmented into Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder and Childhood Disintegrative Disorder. The Autistic Disorder segment is the major segment generating revenue in 2020. This is mainly owing to increasing prevalence of autistic order and growing demand for the effective therapy for the treatment of autism disorder.

According to World Health Organization, about 1 in 270 people are suffering from autism disorder in 2021 that increases the growth of this market. The Asperger Syndrome segment is estimated to register the fastest CAGR of 0.65% for the period 2021-2026. This is mainly owing to increasing neurodevelopment disorder that increases the cases of insomnia and epilepsy that are increasing the growth of this market.

• Schedule a Call

Autism Spectrum Disorder (ASD) Treatment Segment Analysis – By Treatment

The global Autism Spectrum Disorder (ASD) Treatment Market based on Treatment can be further segmented into Behavioral Approaches, Early Intervention, Medication, Dietary Approach and Others. The Behavioral Approaches segment registers for the highest Autism Spectrum Disorder (ASD) Treatment market share in 2020. This is owing to its simplicity to understand and easy for practice. 

Moreover, it does not require a specialist to implement and provide less steps to shape the behaviour. The Early Intervention segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to it enhances the development of child with special needs and support to empower families of children that increases the growth of this market.

Autism Spectrum Disorder (ASD) Treatment Segment Analysis – By Geography

North America dominated the Autism Spectrum Disorder (ASD) Treatment Market with major share of 40% in 2020. This is owing to rising prevalence of autism and pervasive developmental disorders (PDD) and growing awareness about autism among the patient. 

According to Center for Disease Control and Prevention, in 2020 about 1 in 54 children in the U.S. are suffering from autism spectrum disorder (ASD) that increases the need of anticonvulsants and antipsychotics and are rising the market growth. However, Asia Pacific is estimated to outpace all the regions by clocking the highest CAGR of 2.15% during the forecast period 2021-2026 owing to increasing geriatric population and improvement in healthcare centers. 

Autism Spectrum Disorder (ASD) Treatment Market Drivers

Increasing Government Funding & Sponsored Awareness Programs

The increasing funding in government and rising focus on programs for autism for the new autism discoveries are increasing the growth of the Autism Spectrum Disorder (ASD) Treatment Market. Various government agencies are launching new programs in order to provide better facility and are increasing the growth of the Autism Spectrum Disorder (ASD) Treatment Market over 2021-2026.

Growing Technological Advancement

Increasing innovation in technology increases the awareness in E-learning program that increases the growth of this Market. Moreover, rising number of product for various autism type such as asperger syndrome and pervasive developmental disorder that increasing the growth of Autism Spectrum Disorder (ASD) Treatment Market over 2021-2026.

Covid-19 Impact: 

COVID-19 pandemic had greatly affected the growth Autism Spectrum Disorder (ASD) Treatment Market. During pandemic, children with autism needs more support owing to their difficulties in social communication, stereotyped behavior patterns and owing to this pandemic children are not able to access to professional rehabilitation training that are positively impacted the growth of this market. 

Autism Spectrum Disorder (ASD) Treatment Market Challenges

Lack of Skilled Professional to Diagnose Autism Spectrum Disorder

The factors that is set to impede the growth of the Autism Spectrum Disorder (ASD) Treatment Market are the lack of specialist to diagnose autism spectrum disorder. Moreover, time and effort involved in coordinating the care and treatment plan is set to create hurdles for the Autism Spectrum Disorder (ASD) Treatment Market.

Autism Spectrum Disorder (ASD) Treatment Landscape 

Product launches, collaboration, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players within the Autism Spectrum Disorder (ASD) Treatment Market. Autism Spectrum Disorder (ASD) Treatment top 10 companies include, Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals, Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb, Merck & Co., and Par Sterile Products, LLC.

Development

In July 2020, Novartis AG entered into collaboration with Sangamo to develop gene therapies for autism spectrum disorder treatment.

"We also publish more than 100 reports every month in "Lifesciences and Healthcare" Go through the Domain if there are any other areas for which you would like to get a market research study."